Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
11
×
life sciences
national blog main
boston top stories
clinical trials
national top stories
san francisco blog main
san francisco top stories
boston
deals
fda
new york blog main
new york top stories
cancer
cancer drugs
investing
biotech ipos
ipo
startups
third rock ventures
venture capital
abbvie
alexion pharmaceuticals
alzheimer's disease
biogen
blackstone group
cancer immunotherapy
david goldstein
depression
eli lilly
epilepsy
essential tremor
europe blog main
european society for medical oncology
hepatitis b
kiran reddy
major depressive disorder
medicare
mirati therapeutics
What
research
11
×
medicines
biotech
drug
ipo
new
cancer
drugs
aims
companies
disease
gene
genetic
ipos
praxis
precision
proteins
revolution
stop
targets
therapeutics
way
week
abbvie
alike
alliance
alzheimer’s
annual
antonio
approach
arrival
assessed
attention
backed
badylak
based
bio
biotechs
black
called
Language
unset
Current search:
research
×
" boston blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More